Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

Clinical trial NCT03933696 · COMPLETED

Trial details

NCT number: NCT03933696
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Mild Cognitive Impairment Alzheimer Disease Type2 Diabetes

Start date: 2019-01-02
Primary completion: 2025-05-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.